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Functional magnetic resonance imaging 
A B S T R A C T   
Functional magnetic resonance imaging (fMRI) studies consistently demonstrate altered neural activation in 
youth experiencing anxiety and depression in a way that is distinct from adult-onset disorders. However, there is 
a paucity of research systematically reviewing this, and no meta-analyses have been conducted using Activation 
Likelihood Estimation (ALE). The present study conducted a systematic literature search to identify fMRI studies 
in youth (age 4–18) with depression or anxiety disorders. 48 studies with over 2000 participants were identified 
that met the inclusion criteria. Significant foci were extracted. Five ALE meta-analyses were conducted: a) 
activation for both anxiety disorders and depression; b) activation for anxiety disorders only; c) activation for 
depression only; d) deactivation for both anxiety disorders and depression; e) deactivation for depression. Results 
indicated significant clusters of increased activation in the bilateral amygdala for youth with internalising dis-
orders, and specifically for those with anxiety disorders. Significant increased activation extended into the dorsal 
anterior cingulate, entorhinal cortex, the putamen, and the medial and lateral globus pallidus in youth with 
anxiety disorders. These findings help to detail the nature of anxiety being an amygdala hyperactivity disorder, 
whilst also defining the distinction between neural activation patterns in anxiety and depression.   
1. Introduction 
Internalising disorders such as depression and anxiety are becoming 
increasingly common, with 4.4% and 3.6% of the population worldwide 
receiving diagnoses in these areas respectively; this makes depression 
the single largest contributor to global disability, while anxiety is the 
sixth (World Health Organisation, 2017). The prevalence of disorders in 
children and young people (CYP) is of particular concern, with one in 
eight 5–19-year olds now reporting at least one mental health disorder 
(MHD) in the United Kingdom (NHS Digital, 2018). Specifically, while 
the rates of some types of disorders in CYP have remained broadly stable 
over time, internalising disorders, such as anxiety and depression, are 
thought to have increased in the last two decades, with 5.8% of CYP 
reporting difficulties in these areas (NHS Digital, 2018). As 50% of in-
dividuals experiencing lifetime cases of MHDs have first experienced 
symptoms by the age of 14, and 75% by age 18 (Kessler et al., 2005), it is 
clear that childhood and adolescence is a critical period for the onset of 
these difficulties. Thus, this creates an urgent need to better understand 
the processes that underpin their development. 
While the exact mechanisms leading to the onset of childhood 
internalising disorders are not known, it is generally theorised that a 
complex interaction of multiple biological, social, psychological, and 
environmental factors contribute to their development (Bernaras et al., 
2019). Specifically, in terms of CYP, it is also hypothesised that endo-
crine alterations, such as age-related changes and factors associated with 
puberty, may make them more vulnerable to MHDs (Bernaras et al., 
2019). Conversely, Curley et al. (2011) argue that it is the quality of the 
social environment that influences the development and activity of 
neural systems that impact on the onset of such disorders. However, 
whilst the factors contributing to the development of these difficulties 
are disputed, previous functional magnetic resonance imaging (fMRI) 
studies consistently demonstrate altered neural activation in CYP 
experiencing anxiety and depression. It has been suggested that as 
adolescence is characterised by a period of rapid cortical maturation of 
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neural areas involved in emotional processing, emotion regulation, and 
reward processing, factors that cause this development to be altered or 
interrupted may underpin the onset of MHDs in a way that is distinct 
from the mechanisms underlying adult-onset disorders (Kerestes et al., 
2014). 
For instance, Hulvershorn et al’s. (2011) systematic review identi-
fied alterations to a corticolimbic network of key areas that mediate the 
emotional dysregulation associated with adolescent major depressive 
disorder (MDD). This includes functional abnormalities in the hippo-
campus, pre-frontal cortex (PFC), and amygdala. Abnormalities in the 
hypothalamic-pituitary-adrenal axis (HPA) due to the overproduction of 
adrenocorticotropic hormone in the anterior pituitary, and increased 
glucocorticoid release from the adrenal glands, are thought to result in 
damage to hippocampal neurons (Jacobs et al., 2000; Sapolsky et al., 
1990). Conversely, functional abnormalities in the anterior cingulate 
(ACC), dorsolateral and orbitofrontal cortex regions of the PFC are 
considered to have implications for self-referential processing and mood 
stabilising via interactions with limbic and striatal nodes (Pizzagalli, 
2011). Finally, while abnormalities in amygdala activation have 
consistently been identified, the type of alteration has differed, and 
varies according to the task presented (Hulvershorn et al., 2011). 
However, increased amygdala activation generally appears to bias 
perception towards a negative emotional valence in individuals with 
depression (Hulvershorn et al., 2011), particularly in facial recognition 
tasks (Fu et al., 2004; Sheline et al., 2001; Whalen et al., 2002). 
In terms of anxiety, according to Blackford and Pine’s review (2012), 
the amygdala has consistently been shown to play an important role in 
CYP anxiety disorders. Specifically, the most common finding is 
increased activation in this region, particularly when viewing negative 
emotional expressions (Guyer et al., 2008; Hare et al., 2008; C. S. Monk 
et al., 2003). In addition, children with generalised anxiety disorder 
(GAD) have been found to show differences in functional connectivity 
between the amygdala and other brain regions, such as the insula and 
ventrolateral PFC (vlPFC: McClure et al., 2007; C. Monk et al., 2008). 
For instance, lower vlPFC activation has been found to be associated 
with anxiety severity, suggesting dysfunction in vlPFC regulation of the 
amygdala. Abnormalities in PFC activation, including the vlPFC and 
dmPFC, have frequently been implicated in childhood anxiety disorders, 
although the direction of the effect varies by the type of task presented 
(Blackford and Pine, 2012). Finally, similarly to research surrounding 
depression, a review by Iorfino et al. (2016) noted reduced ACC struc-
ture and function and HPA dysregulation in youth with anxiety 
disorders. 
Thus, it appears that several brain regions are involved in the pre-
sentation of both depression and anxiety in CYP, which is not too sur-
prising given that the National Comorbidity Survey (NCS) rated lifetime 
comorbidity as high as 58% (Melton et al., 2016). However, there is a 
paucity of research systematically and rigorously comparing differences 
in activation between the two internalising disorders in CYP (Melton 
et al., 2016). Furthermore, the reviews that have examined neural 
dysfunction in either anxiety or depression are somewhat dated (e.g., 
Blackford and Pine, 2012; Hulvershorn et al., 2011; Kerestes et al., 
2014), which is pertinent given the recent increase in internalising 
disorders amongst CYP (NHS Digital, 2018). In addition, while Kerestes 
et al’s. (2014) review systematically examined functional differences in 
youth with MDD, this only included participants aged 13–25, and so 
information regarding younger CYP was missed. Given that half of 
MHDs first present symptoms before the age of 14 (Kessler et al., 2005), 
this is an important age group to examine. Conversely, Hulvershorn 
et al. (2011) only reported differential activation by task type, and so 
over-arching areas of dysfunction were not identified. In terms of anx-
iety disorders, it appears that relatively less research has been conducted 
with CYP in this area, and while Blackford and Pine (2012) did present a 
literature review on this topic, it was not systematic. 
Specifically, there are limited meta-analyses utilising Activation 
Likelihood Estimation (ALE) to examine differential neural processes 
associated with internalising disorders in CYP. While one ALE study 
(Miller et al., 2015) has been conducted with MDD in youth, finding 
hyperactivation in the subgenual anterior cingulate cortex and vlPFC, no 
comparisons were made with anxiety disorders and inclusion criteria 
incorporated young adults up to age 24. Therefore, the present study 
aims to conduct separate ALE analyses of neuroimaging studies that 
have examined anxiety and depression across CYP only, to enhance 
knowledge of the neural processes involved. In line with this, another 
aim is to identify areas of common activation and deactivation in MDD 
and anxiety due to co-morbidity. A final aim is to compare activation 
and deactivation in relation to the specific tasks employed in functional 
brain imaging studies, in order to elucidate specific processes (e.g. 
cognitive vs. affective tasks). 
2. Methods 
2.1. Literature search 
A computerised search using the databases PubMED and PsycINFO 
was conducted, covering the periods from January 2001 to January 
2020. Grey literature was also searched (e.g. government reports, policy 
statements and issues papers, conference proceedings). Search terms 
were (* = truncated): (fMRI OR MRI OR brain imaging OR magnetic 
resonance imaging) AND (child* or adolescen*) AND (depression OR 
anxi*). January 2001 was chosen as the start date for this review, as the 
first neuroimaging study in adolescent MDD was published in this year 
(see previous review by Kerestes et al., 2014). Additional filters were 
utilised to refine the search further; these included: age (child or 
adolescent), human participants, English language, and journal article 
only. Searches were conducted on titles and abstracts. 
2.1.1. Inclusion and exclusion criteria 
Studies were included if they: a) used task-based fMRI, b) were 
conducted with school age CYP (4–18), c) included participants with a 
diagnosis of MDD and/or an anxiety disorder (generalised, social, sep-
aration, or panic disorder) using recognised diagnostic criteria (in 
accordance with DSM-IV; APA, 2013), d) included a comparison group 
of healthy controls, e) reported the neural activation or deactivation 
co-ordinates in Montreal Neurological Institute (MNI) or Talairach 
space, f) assessed brain regional activation and deactivation using 
contrast analyses and not regression models, g) were published in En-
glish, and h) were published in a peer-reviewed journal article. 
2.1.2. Selected studies 
The literature searches yielded a total of 896 studies. After the 
application of the above criteria, and the removal of duplicates, 739 
studies were excluded. Of the 157 remaining eligible studies, a further 
109 studies were excluded as they failed to provide all necessary in-
formation. Thus, there were 48 eligible studies that contributed to the 
meta-analyses (see Table 1). Paradigms were varied (preventing sepa-
rate analyses of tasks) and included: attention (e.g. sustained, facial 
stimuli); emotion matching; implicit fear; reward paradigms; self- 
perception; Go/No-Go response inhibition; Cyberball peer interaction; 
Iowa Gambling Task (risky decision-making); monetary decision- 
making and emotion regulation tasks. 
2.2. fMRI methods 
Functional Magnetic Resonance Imaging (fMRI) is a non-invasive 
brain imaging technique that indirectly measures neuronal activation 
by way of Blood Oxygen Level Dependency (BOLD). fMRI studies 
employ either a Whole Brain (WB) or a Region of Interest (ROI) 
approach. In a WB approach, significant activation clusters are calcu-
lated by comparing globally across the whole brain, independently of 
threshold limitations. In contrast, an ROI analysis employs a masque or 
small volume correction, to add or remove a region of the brain during 
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Table 1 
Included studies.  
Study name Disorder Task type Sample size Age 
range 
Mean age (SD) Analysis Activation N 
foci    
Clinical HC  Clinical HC    
Halari et al. 
(2009) 
MDD Attention 21 21 14–17 16.2(0.83) 16.3 
(1.1) 
WB Deactivation 9 
Henderson et al. 
(2014) 
MDD Facial-emotion matching 19 18 12–20 17.3(2.4) 15(1.5) WB Deactivation 3 
Ho et al. (2014) MDD Implicit fear facial affect 
recognition 
26 37 13–17 15.8(1.4) 16.1 
(1.2) 
WB Deactivation 3 
Sharp et al. (2014) MDD Reward anticipation 14 19 10–16 13.42(1.78) 13.71 
(1.85) 
ROI Deactivation 2 
Blom et al. (2015) MDD Emotional face processing 31 36 13–18 16 16.1 WB Activation 9 
Bradley et al. 
(2016) 
MDD Self-perception word task 23 18 12–20 16.62(2.51) 16.12 
(1.54) 
WB Activation 2 
Chuang et al. 
(2016) 
MDD Go/no-go 82 24 12–17 15.72(1.10) 15.89 
(1.42) 
WB Activation 1 
Diler et al. (2013) MDD Emotional face processing 10 10 12–17 15.9(1.10) 15.6 
(1.2) 
WB Activation 9 
Diler et al. (2014) MDD Go/no-go 10 10 12–17 15.9(1.10) 15.6 
(1.1) 
WB Activation 4 
Gaffrey et al. 
(2013) 
MDD Emotional face processing 23 31 4–6† 5.04(0.76) 5.06 
(0.89) 
Both Activation 8 
Groschwitz et al. 
(2016) 
MDD Cyberball peer interaction 14 15  15.9(1.60) 14.5 
(1.70) 
ROI Activation 1 
Harms et al. 
(2019) 
MDD Cyberball peer interaction 87 39  14.87(1.58) 14.43 
(1.51) 
WB Activation 1 
Ho et al. (2015) MDD Facial-emotion matching 26 37 13–17 16.1(0.30) 16(0.2) WB Activation 7 
Ho et al. (2016) MDD Emotional face processing 26 37 13–17 16.1(0.30) 16(0.2) WB Activation 6 
Holt et al. (2016) MDD Self-referential memory 56 30 11–17 15.69(1.17) 15.76 
(1.39) 
WB Activation 1 
Jankowski et al. 
(2018) 
MDD Cyberball peer interaction 87 39 11–17 14.89(1.67) 14.43 
(1.51) 
WB Activation 1 
Pan et al. (2011) MDD Go/no-go 30 14 13–17 15.87(1.55) 15.21 
(1.42) 
WB Activation 3 
Pan et al. (2013a) MDD Emotional face processing 15 15  15.87(1.55) 15.27 
(1.39)     
WB Activation 4        
Pan et al. (2013b) MDD Iowa Gambling Task 29 13 12–17 16.0(1.18) 15.15 
(1.46) 
WB Activation 18 
Quevedo et al. 
(2018) 
MDD Facial recognition 43 38  14.73(1.76) 14.46 
(1.52) 
WB Activation 10 
Redlich et al. 
(2018) 
MDD Face matching 20 21 15–18 16.0(1.03) 16.6 
(1.08) 
ROI Activation 2 
Roberson-Nay 
et al. (2006) 
MDD Facial memory encoding 10 23 8–17† 13.8(2.7) 14.8 
(2.2) 
WB Activation 3 
Shad et al. (2011) MDD Monetary decision making 22 22 12–20 15.0(2.10) 16.0 
(2.10) 
WB Activation 1 
Tao et al. (2012) MDD Emotional face processing 19 21 11–18 14.2(1.90) 14.9 
(2.50) 
Both Activation 41 
Chantiluke et al. 
(2012) 
MDD Sustained attention 20 21 13–18 16.2(0.80) 16.3 
(1.10) 
WB Both 7 
Forbes et al. 
(2009) 
MDD Reward processing 15 28 8–17† 13.5(2.10) 13.1 
(2.60) 
ROI Both 7 
Olino et al. (2011) MDD Reward anticipation 10 16 8–16† 13.31(2.49) 13.31 
(2.49) 
Both Both 2 
Perlman et al. 
(2012) 
MDD Emotion regulation 14 14 12–17 15.7(1.50) 15.1 
(1.60) 
Both Both 6 
Yang et al. (2009) MDD Stop-signal 13 13 13–17 16.0(1.50) 15.8 
(1.50) 
WB Both 4 
Yang et al. (2010) MDD Facial-emotion matching 12 12 12–17 15.9(1.40) 15.4 
(1.70) 
Both Both 7 




Emotional face processing 5 MDD; 12 
anxiety 




ROI Both 2 




Emotional face processing 26 MDD; 16 
anxiety 




ROI Activation 5 
Benson et al. 
(2015) 
Anxiety Monetary reward 18 20 8–18† 12.13(2.40) 13.24 
(2.30) 
WB Activation 2 
Carlisi et al. 
(2017) 
Anxiety Face attention 14 19  14.05(2.16) 14.16 
(2.37) 
Both Activation 6 
Galvan et al. 
(2014) 
Anxiety Risky decision making 17 15 8–17† 13.05(2.87) 13.69 
(2.28) 
WB Activation 2 
Guyer et al. 
(2012) 
Anxiety Monetary incentive delay 32 26  13.02(2.85) 13.99 
(2.44) 
ROI Activation 1 
Jarcho et al. 
(2015) 
Anxiety Social feedback task 15 24 8–17† 12.79(3.39) 13.68 
(2.39) 
WB Activation 2 
(continued on next page) 
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statistical analysis. ROI analyses are favourable if previous studies 
highlight the significance of the region and tend to inflate the signifi-
cance of the meta-analysis as a whole. ROI analyses were reported by 
some studies included in the current meta-analyses and so additional 
analyses were conducted to examine whether these ROI studies biased 
the overall findings. 
2.3. Quantitative data synthesis: ALE meta-analyses 
BrainMap GingerALE version 3.0.2 software (Laird et al., 2005; 
Turkeltaub et al., 2012) was used here. We applied the updated version 
of the ALE approach (Eickhoff et al., 2009) to conduct the meta-analyses 
using Talairach or Montreal Neurological Institute (MNI) coordinates 
(“foci”) from neuroimaging results. Foci were extracted from publica-
tions examining children and adolescents (age range: 4 – 20 years of 
age), checked by two researchers (EA, SJB). Papers that reported co-
ordinates in standard Talairach space were converted into MNI using the 
GingerALE software. Text files were then created, listing the study 
names, number of subjects and a list of the foci (MNI coordinates) 
associated with neural activation (but not deactivation) to subliminal 
stimuli. Specifically, we conducted five separate ALE meta-analyses: a) 
activation for both anxiety disorders and MDD; b) activation for anxiety 
disorders only; c) activation for MDD only; d) deactivation for both 
anxiety disorders and MDD; e) deactivation for MDD (there were not 
enough contributing deactivation studies to examine anxiety disorders 
separately). Text files of foci were cross-checked by two researchers as 
above. Text files for each meta-analysis are available on request. 
ALE is a statistical modelling technique specifically designed to 
address the variance between and within fMRI studies. This technique 
uses the total foci coordinates reported in each study to build a 3-dimen-
sional Gaussian kernel to provide a modelled activation (MA) map for 
each study. The position of foci can be a consequence of between-study 
variances, such as the different templates used, or the differences be-
tween participants, and as such these two main issues are considered in 
the parameters of the kernel. This is done by weighting the foci reported 
by the number of participants in each study. Finally, the MA maps for 
each study are combined for each separate meta-analysis, creating an 
experimental ALE map. This is tested against the null hypothesis that 
there is random variation in relation to the spatial orientation of neural 
activation for the specific meta-analysis (e.g. subliminal presentation of 
faces), but that the within-study variation is fixed. A random effect 
model is employed by the ALE analysis technique, which assumes a 
higher than chance likelihood of consensus between different experi-
ments, but not in relation to activation variance within each study. The 
null distribution map is permuted by the number of studies that 
constitute each meta-analysis. To correct for multiple comparisons, we 
used a threshold of p < 0.05 False Discovery Rate (FDR), and chose a 
minimum cluster size of 100 mm3, as per most studies. We used an 
anatomical image overlay program called Mango (http://ric.uthscsa. 
edu/mango) to illustrate the results of our meta-analyses. GingerALE 
employs the term “contributing studies”, to describe studies that are 
located within the boundaries of ALE cluster. However, this does not 
discount other studies that might be located near these boundaries but 
outside of the cluster, which could have also contributed to it. 
2.3.1. Sensitivity analyses 
Given the wide age range (4–20 years) of participants in the included 
studies and the neurobiological and clinical changes that occur during 
this period of development, sensitivity analyses were conducted to 
establish if any significant findings varied by age group. However, 
almost all studies that included children also included adolescents in one 
heterogeneous sample, and so no simple method of categorising studies 
into child and adolescent samples was available. As such, two sensitivity 
analyses were conducted. Sensitivity analysis 1 excluded the only study 
solely involving children as participants (Gaffrey et al., 2013); aged 4–6 
years). Sensitivity analysis 2 excluded all studies that involved partici-
pants younger than 11 years of age, regardless of the upper age limit. 
3. Results 
Of the 896 fMRI studies found during searching, 739 did not meet the 
inclusion criteria, and 108 failed to provide all the necessary informa-
tion. There was also one study that did not present co-ordinates, and 
these could not be obtained from the authors. Thus, there were 48 
remaining studies that contributed to the five meta-analyses reported 
here. In the first set of meta-analyses examining activation, 45 studies 
were included across both types of internalising disorders; there were 
then 27 for the MDD analysis, and 18 for the anxiety analysis. In terms of 
the analyses for deactivation, 12 studies were included across both 
internalising disorders; there were then 11 for the MDD analysis. As 
Table 1 (continued ) 
Study name Disorder Task type Sample size Age 
range 
Mean age (SD) Analysis Activation N 
foci    
Clinical HC  Clinical HC    
Maslowsky et al. 
(2010) 
Anxiety Probe detection, event-related 
design (facial-emotion) 
14 10  13.35(2.10) 14.5 
(1.40) 
ROI Activation 4 
McClure et al. 
(2007) 
Anxiety Face-emotion rating 15 20  11.67(1.97) 12.19 
(2.10) 
WB Activation 11 
Monk et al. (2006) Anxiety Face attention 18 15 9–17† 12.28(2.05) 13.53 
(2.41) 
ROI Activation 1 
Smith et al. (2018) Anxiety Social appraisal 14 17 8–17† 13.18(3.32) 13.35 
(2.94) 
WB Activation 1 
Speilberg et al. 
(2015) 
Anxiety Cognitive peer evaluation 16 26 8–17† 12.7(3.30) 13.3 
(2.80) 
ROI Activation 1 
Strawn et al. 
(2012) 
Anxiety Continuous performance with 
distractors 
10 10 11–17 14.3(2.0) 13.3 
(3.0) 
WB Activation 2 
Swartz et al. 
(2014a) 
Anxiety Emotional faces - shifting 
attention 
34 35 7–19† 13.84(3.30) 15.2 
(3.90) 
ROI Activation 1 
Swartz et al. 
(2014b) 
Anxiety Facial-emotion matching 34 19 8–19† 13.94(3.20) 15.07 
(4.0) 
WB Activation 20 
Williams et al. 
(2015) 
Anxiety Anticipation 20 20 8–12† 9.8(1.20) 9.85 
(1.10) 
Both Activation 9 
Yin et al. (2017) Anxiety Emotional face processing 20 14 13–18 15.7(1.70) 15.5 
(1.70) 
WB Activation 8 
Guyer et al. 
(2008) 
Anxiety Cognitive peer evaluation 14 14  12.3(2.76) 12.58 
(2.54) 
Both Both 5 
MDD = major depressive disorder. 
† = removed for sensitivity analyses. 
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there was only one study focusing on anxiety disorders, a meta-analysis 
was not conducted. See Table 1 for details of included studies. The 
significant clusters are reported in Table 2 and sensitivity analyses in 
Table 3. 
3.1. Meta-analysis one: significant ALE clusters for activation across 
internalising disorders 
From 233 foci, 2169 subjects and 45 separate experiments, two 
clusters were found that survived the FDR correction threshold (see 
Fig. 1a). Cluster one was identified with two peaks in the left hemisphere 
and was primarily located in the amygdala (57% of studies), extending 
slightly into Brodmann area 34 (24.8%) and 28 (5.6%), the putamen 
(4.2%), the medial globus pallidus (4.2%), and the lateral globus pal-
lidus (4.2%). Cluster two was identified with two peaks in the right 
hemisphere and was primarily located in the amygdala (45.6%), 
extending slightly into Brodmann area 34 (32.4%) and 28 (4.4%), the 
putamen (14.7%), and the lateral globus pallidus (2.9%). Sensitivity 
analysis 1 included 225 foci, 2115 subjects and 44 experiments. The co- 
ordinates of both clusters identified were identical to the main analysis. 
Sensitivity analysis 2 included 175 foci, 1613 subjects, and 31 experi-
ments and identified two clusters. Cluster one was broadly similar to 
that in the main analysis; it consisted of two peaks in the left hemisphere 
and was primarily located in the amygdala (62.3%), extending into 
Brodmann area 34 (13.7%) and 28 (6.2%), the medial (7.5%) and lateral 
(4.8%) globus pallidus, and the putamen (4.8%). Cluster two was 
identified with four peaks in the right hemisphere and was primarily 
located in the putamen (52.8%), amygdala (28.3%), lateral globus pal-
lidus (11%), and Brodmann area 34 (5.5%) and 28 (2.4%). 
3.2. Meta-analysis two: significant ALE clusters for activation in anxiety 
disorders 
From 79 foci, 719 subjects and 18 separate experiments, two clusters 
were found that survived the FDR correction threshold (see Fig. 1b). 
Cluster one was found with two peaks in the left hemisphere and was 
primarily located in the amygdala (55.8%), extending slightly into 
Brodmann area 34 (28.5%) and 28 (7.3%), and the medial globus pal-
lidus (7.9%). Cluster two was found with two peaks in the right hemi-
sphere and was primarily located in the amygdala (56.4%), extending 
slightly into Brodmann area 34 (23.8%) and 28 (7.9%), the putamen 
(6.9%), and the lateral globus pallidus (5%). 
Sensitivity analysis 1 was not required as results of the Gaffrey et al. 
(2013) study pertained only to MDD. Sensitivity analysis 2 included 39 
foci, 319 subjects, and 8 experiments. Two clusters were found. Both 
clusters were broadly similar to those identified in the main analysis. 
Cluster one consisted of three peaks in the left hemisphere and was 
primarily located in the amygdala (58.9%), medial globus pallidus 
(14.4%), Brodmann area 28 (13.3%) and 34 (12.2%), and the lateral 
globus pallidus (1.1%). Cluster two consisted of one peak in the right 
hemisphere and was primarily located in the amygdala (56.9%), puta-
men (19.6%), lateral globus pallidus (13.7%), and Brodmann area 28 
(5.9%) and 34 (3.9%). 
3.3. Meta-analysis three: significant ALE clusters for activation in MDD 
No significant clusters were reported by the ALE analysis. 
3.4. Meta-analysis four: significant ALE clusters for deactivation across 
internalising disorders 
No significant clusters were reported by the ALE analysis. 
3.5. Meta-analysis five: significant ALE clusters for deactivation in MDD 
No significant clusters were reported by the ALE analysis. 
4. Discussion 
Findings from the present meta-analysis of 48 fMRI studies empha-
sise significant clusters of activation during a range of emotion- 
regulation and decision-making tasks in the bilateral amygdala for 
CYP with internalising disorders, and specifically for those with anxiety 
disorders. Significant activation also extended into the dorsal anterior 
cingulate (dACC: Brodmann area 32), entorhinal cortex (Brodmann area 
28), the putamen, and the medial and lateral globus pallidus in CYP with 
anxiety disorders. Conversely, no significant clusters of activation were 
identified for the MDD group alone. Finally, no significant clusters of 
deactivation were found in any of the analyses. 
Previous studies have shown that chronic anxiety disorders in gen-
eral are associated with increased bilateral amygdala activation, ac-
cording to a neurosynth (Yarkoni et al., 2011; http://neurosynth.org) 
meta-analysis of 95 studies (using the search term ‘anxiety disorders’). 
Fig. 2 provides a comparison between our findings and the results of the 
neurosynth search; as can be seen, areas of activation are similar. As the 
neurosynth search also included studies with adult disorders, this pro-
vides some evidence that areas of neural activation in anxiety disorders 
are consistent across age groups. Closer inspection of seven of the neu-
roimaging studies that specifically examined neural activation in ado-
lescents with anxiety disorders demonstrated that in addition to 
Table 2. 
Locations of MNI peak coordinates with significant ALE values.  
Cluster Anatomical region Peak Peak voxel coordinates Cluster size (mm3) ALE value (x10− 2) Contributing experiments    
x y Z   N % 
Meta-analysis 1 
1 L amygdala, parahippocampal gyrus     3904  13 29 
Peak 1 − 20 − 2 − 18  0.034266   
Peak 2 − 10 − 4 − 18  0.025981           
2 R amygdala, parahippocampal gyrus, lentiform nucleus     2512  8 18 
Peak 1 22 − 2 − 18  0.029863   
Peak 2 32 − 6 − 12  0.021728   
Meta-analysis 2 
1 L amygdala, parahippocampal gyrus, lentiform nucleus     3144  8 44 
Peak 1 − 20 − 2 − 20  0.030207   
Peak 2 − 12 − 6 − 14  0.019187           
2 R amygdala, parahippocampal gyrus     1848  5 28 
Peak 1 16 − 6 − 20  0.019194   
Peak 2 22 − 4 − 18  0.018806   
Abbreviations: ALE, activation likelihood estimation; MNI, Montreal Neurological Institute; R, right; L, left. 
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amygdala activation, other brain regions during emotion-regulation and 
decision-making tasks were also implicated. For example, in response to 
uncertainty, increased anterior and posterior cingulate cortex activation 
was reported (Krain et al., 2008), while response to uncomfortable peer 
interaction increased amygdala-cingulate functional coupling, with 
reduced nucleus accumbens activation in anticipation of peer feedback 
(Spielberg et al., 2014). Moreover, amygdala and anterior hippocampus 
activation in response to emotional faces was associated with met versus 
val heterozygous BDNF polymorphism in anxious and depressed ado-
lescents, suggesting that genetic susceptibility may underlie dysfunc-
tional adolescent affect regulation (Lau et al., 2010). Finally, deficits in 
fear extinction recall are suggested to underlie anxiety disorders in ad-
olescents; during a fear-recall fMRI task, anxiety disorders have been 
shown to be associated with negative functional connectivity between 
prefrontal cortex and limbic regions (Ganella et al., 2017). 
In contrast, chronic or recurrent MDD is associated with persistent 
exposure to stress-induced glucocorticoids, which may have neurotoxic 
effects associated with amygdala shrinkage (Hamidi et al., 2004). 
Structural amygdala alterations may lead to reduced activation in those 
with MDD, given that healthy adult responses to fearful faces are probes 
for increased amygdala activation (Fusar-Poli et al., 2009; Hulvershorn 
et al., 2011). Similarly, in healthy adolescents, bilateral amygdala 
activation was greater when fearful faces were shown, compared to 
neutral expressions. Healthy children, on the other hand, had less 
amygdala activation with fearful than neutral face probes (Baird et al., 
1999). These disparate findings preliminarily suggest an age-related 
shift toward the amygdala’s sensitivity to fear in typically developing 
children and may provide some explanation for the lack of significant 
findings in the MDD group in the current meta-analysis. 
Interestingly, our sensitivity analysis including studies involving 
only adolescents identified more frequent increased activation in the 
putamen than the amygdala across internalising disorders. This suggests 
potential differences in neural activation between younger children and 
Table 3 
Locations of MNI peak coordinates with significant ALE values: Sensitivity analyses.  
Cluster Anatomical region Peak Peak voxel 
coordinates 
Cluster size (mm3) ALE value (x10− 2) Contributing 
experiments    
x y z   N % 
Meta-analysis 1: Sensitivity analysis 1 
1 L amygdala, parahippocampal gyrus     3960  13 30   
Peak 1 − 20 − 2 − 18  0.034266     
Peak 2 − 10 − 4 − 18  0.025981   
2 R amygdala, parahippocampal gyrus, lentiform nucleus     2104  7 16   
Peak 1 22 − 2 − 18  0.028874     
Peak 2 32 − 6 − 12  0.021728   
Meta-analysis 1: Sensitivity analysis 2 
1 L amygdala, parahippocampal gyrus, lentiform nucleus     2688  8 26   
Peak 1 − 20 − 8 − 16  0.026379     
Peak 2 − 12 − 6 − 14  0.018838   
2 R putamen, amygdala, lentiform nucleus, parahippocampal gryus     2112  7 23   
Peak 1 22 − 2 − 18  0.024095     
Peak 2 32 − 6 − 12  0.021712     
Peak 3 28 − 6 4  0.01900     
Peak 4 30 − 8 − 4  0.011296   
Meta-analysis 2: Sensitivity analysis 2 
1 L amygdala, parahippocampal gyrus, lentiform nucleus     2040  5 63   
Peak 1 − 12 − 6 − 14  0.018502     
Peak 2 − 18 − 8 − 14  0.017712     
Peak 3 − 24 2 − 26  0.0096   
2 R amygdala, parahippocampal gyrus     1048  3 38   
Peak 1 16 − 6 − 20  0.015996   
Abbreviations: ALE, activation likelihood estimation; MNI, Montreal Neurological Institute; R, right; L, left. 
Fig 1.. a. ALE results: Analysis 1 (internalising disorders). b. ALE results: 
Analysis 2 (anxiety disorders). 
Fig 2.. a. ALE results: Analysis 2 (anxiety disorders). 2. Neurosynth results 
(anxiety disorders). 
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older adolescents. A possible explanation for this is the cognitive inhi-
bition spill-over hypothesis, whereby intentional cognitive inhibition 
spills over to inhibit neural responses to affective stimuli (Stoycos et al., 
2017). It could be that in older adolescents with a more developed 
(although not fully developed) prefrontal cognitive inhibition system, 
the cognitive inhibition spills over to inhibit amygdala responses. 
Indeed, previous research by Stoycos et al. (2017) into the spill-over 
hypothesis found that younger children had less activation in the ACC 
and bilateral IFG, regions that are pivotal for cognitive inhibition, sug-
gesting this may be more likely in older adolescents. Furthermore, 
youths’ internalising symptoms were positively associated with activa-
tion in the right pallidum and putamen, but not the amygdala. Berkman 
et al. (2009) earlier work supports this, finding the increased functional 
activity in the rIFG was linked with decreased activity in the amygdala, 
providing evidence for the inhibitory spill-over hypothesis. However, as 
only one of the sensitivity analyses in our study revealed this finding, 
and a smaller sample of studies was utilised, caution should be taken 
when interpreting our results. Further research is needed in this area. 
4.1. Limitations 
There are a few limitations that should be considered before iden-
tifying potential implications of this meta-analysis. First, fMRI data 
cannot ascertain cause or consequence, and specifically in this case, 
whether increased bilateral amygdala, limbic and ACC activation is a 
cause or a consequence of anxiety disorders in CYP. Second, the number 
of studies with heterogeneous samples (e.g., age, duration of illness, 
anxiety disorder versus MDD, type of treatment) prevent definitive 
conclusions, although the findings of this study correspond to current 
findings in the literature. More nuanced analyses were not possible due 
to the broad age range of participants in the studies included in our 
meta-analyses. Thus, future research should seek to investigate neural 
activation of internalising disorders in discrete age groups of CYP, so 
that more accurate comparisons can then be drawn between children 
and adolescents. Third, ALE is a ‘vote-counting’ meta-analytic method 
that determines the number of common foci across fMRI studies, cor-
responding to the likelihood of a specific cluster, which may introduce a 
higher level of false positives. That said, ALE is a robust measure that 
reflects and confirms the majority of the findings in the literature and 
helps to clarify the most significant regions of interest for further study. 
Finally, there were not enough studies within the different types of fMRI 
task or diagnostic group to run separate sub-analyses. Thus, although no 
significant clusters of activation were identified for the MDD group 
alone, this may be due to a lack of MDD foci to evidence significant 
findings, as opposed to a true lack of activation in these areas. Indeed, 
some of the foci contributing to the clusters in the internalising disorders 
analysis were from studies investigating MDD, suggesting some activa-
tion in these areas. This highlights the need for further studies exam-
ining the neural correlates of anxiety disorders and MDDs in CYP. 
4.2. Implications and future directions 
Significantly increased activation in ACC and limbic regions 
(particularly bilateral amygdala) to fearful and emotional fMRI tasks 
were observed in CYP with anxiety disorders. This is consistent with 
emerging evidence that indicates that greater illness severity is associ-
ated with greater grey matter reductions in the ACC in individuals with 
anxiety disorders (Iorfino et al., 2016). The ACC is an integrative hub for 
executive functions and socially driven interactions of the type associ-
ated with conflict monitoring and impulse control (Lavin et al., 2013). In 
adolescents with anxiety disorders, the connectivity between the ACC 
and amygdala alters according to age and is associated with a failure to 
establish effective limbic connectivity in childhood, or effective 
top-down affect regulation during adolescence and adulthood (Kujawa 
et al., 2016). As such, amygdala hypersensitivity and heightened 
top-down activation of the ACC may reflect hyper-regulation of limbic 
responses in CYP with anxiety disorders. Thus, findings from the present 
study help to detail the nature of anxiety as amygdala hyperactivity 
disorder, whilst also helping to define the distinction between the acti-
vation patterns during anxiety and depression. 
The long-term negative impact of internalising disorders, such as 
anxiety and depression, is well established, with evidence suggesting 
poorer wellbeing, reduced economic and social productivity, and 
increased morbidity and mortality (McLaughlin, 2011). Thus, effective 
strategies for early identification, intervention and treatment are ur-
gently needed, in order to reduce the likelihood of negative outcomes. 
Based on the findings in the present study regarding the role of the ACC, 
future research may want to consider studies that link common 
cognitive-affective responses to these neural patterns in CYP with anx-
iety disorders; this in turn may help to identify biomarkers for early 
prevention. This could be particularly useful in the field of ‘personalised 
psychiatry’, whereby neurobiological markers indicating prognosis or 
potential treatment targets could be used to guide treatment and help 
provide person-centred care (Iorfino et al., 2016). However, in order to 
achieve this, further research is first needed to establish the biomarkers 
that predict the onset of internalising disorders, the clinical utility of 
specific neurobiological markers, and the ability of these biomarkers to 
predict clinical response to pharmacotherapy. 
Furthermore, results regarding increased amygdala activation in the 
present study may also have broader utility for practitioners in the field 
of CYP mental health. For example, findings can be used to inform other 
types of treatment, such as psychological therapies (e.g., cognitive 
behavioural therapy [CBT]). There is already some evidence to suggest 
that effective CBT treatment for anxiety disorders is associated with a 
reduction in anxiety symptoms and the startle response (a measure of 
amygdala reactivity), as well as reduced amygdala activation to nega-
tive emotional stimuli (Bakker et al., 2011). Additional research sug-
gests that CBT may work by strengthening connections between the 
amygdala and prefrontal cortex regions involved in cognitive control, 
potentially enhancing top-down control of affective processes that are 
dysregulated in internalising disorders (Shou et al., 2017). Therefore, 
further research is needed into the types of therapy most effective at 
reducing amygdala activation, and the specific components of different 
therapies most likely to achieve this. 
Finally, future research should also seek to identify areas of signifi-
cant activation in other types of internalising disorders, in order to 
establish if similar implications could be applied. For instance, while the 
present study focused on MDD and anxiety disorders, other research 
appears to suggest similar neural activation in disorders such as post- 
traumatic stress disorder and bipolar disorder (Iorfino et al., 2016; 
Shou et al., 2017), although syntheses of these studies are lacking. 
4.3. Conclusions 
The present study was the first of its kind to conduct a meta-analyses 
utilising ALE to examine differential neural processes associated with 
depression and anxiety disorders in CYP. Findings revealed significant 
clusters of activation during a range of emotion-regulation and decision- 
making tasks in the bilateral amygdala for CYP with internalising dis-
orders, and specifically for those with anxiety disorders. Significant 
activation also extended into the dACC (Brodmann area 32), entorhinal 
cortex (Brodmann area 28), the putamen, and the medial and lateral 
globus pallidus in CYP with anxiety disorders. This supports previous 
research in the field, and findings can be used to inform future research 
in terms of early identification of CYP with internalising disorders, as 
well as the development of effective pharmacological and psychological 
treatments. 
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cingulate cortex: an integrative hub for human socially-driven interactions. Front 
Neurosci 7, 1–4 (May)10.3389/fnins.2013.00064.  
McClure, E., Monk, C., Nelson, E., Parrish, J., Adler, A., Blair, R., Fromm, S., Charney, D., 
Leibenluft, E., Ernst, M., Pine, D., 2007. Abnormal attention modulation of fear 
circuit function in pediatric generalized anxiety disorder. Arch. Gen. Psychiatry 64, 
97–106. 
McLaughlin, K.A., 2011. The public health impact of major depression: a call for 
interdisciplinary prevention efforts. Prevention Science 12 (4), 361–371. https://doi. 
org/10.1007/s11121-011-0231-8. 
Melton, T., Croarkin, P., Strawn, J., McClintock, S., 2016. Comorbid anxiety and 
depressive symptoms in children and adolescents: a Systematic review and analysis. 
J. Psychiatr. Pract. 22 (2), 84–98, 10.1016/j.physbeh.2017.03.040.  
Miller, C.H., Hamilton, J.P., Sacchet, M.D., Gotlib, I.H., 2015. Meta-analysis of functional 
neuroimaging of major depressive disorder in youth. JAMA Psychiatry 72 (10), 
1045–1053, 10.1001/jamapsychiatry.2015.1376.  
Monk, C.S., McClure, E.B., Nelson, E.E., Zarahn, E., Bilder, R.M., Leibenluft, E., 
Charney, D., Ernst, M., Pine, D., 2003. Adolescent immaturity in attention-related 
brain engagement to emotional facial expressions. Neuroimage 20, 420–428. 
Monk, C., Telzer, E., Mogg, K., Bradley, B., Mai, X., Louro, H., Chen, G., McClure- 
Tone, E., Ernst, M., Pine, D., 2008. Amygdala and ventrolateral prefrontal cortex 
activation to masked angry faces in children and adolescents with generalized 
anxiety disorder. Arch Gen Psychiatry 65, 568–576. 
Digital, N.H.S., 2018. Mental health of children and young people in England, 2017: 
summary of key findings. In NHS (Issue November 2018). https://doi.org/10.2307/ 
j.ctv39x8m4.19. 
Pizzagalli, D.A., 2011. Frontocingulate dysfunction in depression: toward biomarkers of 
treatment response. Neuropsychopharmacology 36, 183–206. 
Sapolsky, R.M., Uno, H., Rebert, C.S., Finch, C.E., 1990. Hippocampal damage associated 
with prolonged glucocorticoid exposure in primates. J. Neurosci. 10, 2897–2902. 
Sheline, Y.I., Barch, D.M., Donnelly, J.M., Ollinger, J.M., Snyder, A.Z., Mintun, M.A., 
2001. Increased amygdala response to masked emotional faces in depressed subjects 
resolves with antidepressant treatment: an fMRI study. Biol. Psychiatry 50, 651–658. 
Shou, H., Yang, Z., Satterthwaite, T.D., Cook, P.A., Bruce, S.E., Shinohara, R.T., 
Rosenberg, B., Sheline, Y.I., 2017. Cognitive behavioral therapy increases amygdala 
connectivity with the cognitive control network in both MDD and PTSD. 
NeuroImage: Clinical 14, 464–470, 10.1016/j.nicl.2017.01.030.  
Spielberg, J.M., Jarcho, J.M., Dahl, R.E., Pine, D.S., Ernst, M., Nelson, E.E., 2014. 
Anticipation of peer evaluation in anxious adolescents: divergence in neural 
activation and maturation. Soc. Cogn. Affect Neurosci. 10 (8), 1084–1091, 10.1093/ 
scan/nsu165.  
Stoycos, S.A., Piero, L.Del, Margolin, G., Kaplan, J.T., Saxbe, D.E, 2017. Neural correlates 
of inhibitory spillover in adolescence: associations with internalizing symptoms. Soc. 
Cogn. Affect. Neurosci. 12 (10), 1637–1646, 10.1093/scan/nsx098.  
Turkeltaub, P.E., Eickhoff, S.B., Laird, A.R., Fox, M., Wiener, M., Fox, P., 2012. 
Minimizing within-experiment and within-group effects in activation likelihood 
estimation meta-analyses. Hum. Brain Mapp. 33 (1), 1–13, 10.1002/hbm.21186.  
Whalen, P.J., Shin, L.M., Somerville, L.H., McLean, A.A., Kim, H., 2002. Functional 
neuroimaging studies of the amygdala in depression. Semin. Cin. Neuropsychiatr. 7, 
234–242. 
World Health Organisation. (2017). Depression and other common mental disorders: global 
health estimates. 
Yarkoni, T., Poldark, R., Nichols, T., Van Essen, D., Wager, T., 2011. Large-scale 
automated synthesis of human functional neuroimaging data. Nat. Methods 8, 
665–670. 
E. Ashworth et al.                                                                                                                                                                                                                               
